Paper32289481
Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease.
Kai J and 11 others. Free Radic Biol Med, 2020. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease. Papers, record 32289481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32289481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Diseases, Alcoholic | Major topic |
| Pyroptosis | Major topic |
| Animals | |
| Flavonoids | |
| GTP Phosphohydrolases | |
| Hepatocytes | |
| Male | |
| Mice | |
| Mice, Inbred ICR | |
| Mitochondria | |
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | |
| Reactive Oxygen Species |
Source PubMed
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42908686 | Clinical efficacy and multi-target mechanisms of liver-dispersing, bile-inducing, and heat-clearing TCM formulas in cholelithiasis: network meta-analysis, network pharmacology, and molecular docking study. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42908686 | PubMed |
| 42751505 | Flavonoids: biological activities, nutritional and immunological aspects, therapeutic potential, food applications, and human health benefits-A comprehensive review. | Front Nutr | 2026 | https://conductscience.org/library/papers/42751505 | PubMed |
| 42614562 | Immunometabolic pathways in liver fibrosis: current evidence for selected plant-derived metabolites associated with traditional Chinese medicine. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42614562 | PubMed |
| 42199808 | Natural Product Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Targeted Mitochondrial Quality Control. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42199808 | PubMed |
| 42039261 | Oroxylin A ameliorates hepatic steatosis and non-alcoholic fatty liver disease through the regulation of CPT1A m6A methylation in hepatocytes. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/42039261 | PubMed |
| 41613015 | Bidirectional Regulation of NLRP3 Inflammasome and Mitochondrial Quality Control in Sepsis: Mechanisms and Therapeutic Implications. | Mediators Inflamm | 2026 | https://conductscience.org/library/papers/41613015 | PubMed |
| 41112736 | MRPL44 regulates lipid metabolism in metabolic dysfunction-associated steatotic liver disease through BNIP3-mediated mitophagy. | Front Nutr | 2025 | https://conductscience.org/library/papers/41112736 | PubMed |
| 40956539 | Calcium signalling and organelle crosstalk in cardiovascular disease: an interplay of cardiac cell death pathways. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40956539 | PubMed |
| 40667485 | Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis. | Open Life Sci | 2025 | https://conductscience.org/library/papers/40667485 | PubMed |
| 40102927 | Oroxylin A reverses SHP-2 oxidative inactivation in GPVI signaling to suppress platelet activation and thrombus formation. | Thromb J | 2025 | https://conductscience.org/library/papers/40102927 | PubMed |
| 39917567 | Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/39917567 | PubMed |
| 39717669 | Exosomes from IH- Induced bEnd3 Cells Promote OSA Cognitive Impairment via miR-20a-5p/MFN2 Mediated Pyroptosis of HT22 Cells. | Nat Sci Sleep | 2024 | https://conductscience.org/library/papers/39717669 | PubMed |
| 39669199 | Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39669199 | PubMed |
| 39253100 | Natural Flavonoid-Derived Enzyme Mimics DHKNase Balance the Two-Edged Reactive Oxygen Species Function for Wound Healing and Inflammatory Bowel Disease Therapy. | Research (Wash D C) | 2024 | https://conductscience.org/library/papers/39253100 | PubMed |
| 39011036 | ROS induced pyroptosis in inflammatory disease and cancer. | Front Immunol | 2024 | https://conductscience.org/library/papers/39011036 | PubMed |
| 38863972 | Renal Tissue-Derived Exosomal miRNA-34a in Diabetic Nephropathy Induces Renal Tubular Cell Fibrosis by Promoting the Polarization of M1 Macrophages. | IET Nanobiotechnol | 2024 | https://conductscience.org/library/papers/38863972 | PubMed |
| 38666911 | Advances in Flavonoid Research: Sources, Biological Activities, and Developmental Prospectives. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/38666911 | PubMed |
| 38621001 | Natural compounds may contribute in preventing SARS-CoV-2 infection: a narrative review. | Food Sci Hum Wellness | 2022 | https://conductscience.org/library/papers/38621001 | PubMed |
| 38343611 | Progress in the Correlation Between Inflammasome NLRP3 and Liver Fibrosis. | J Clin Transl Hepatol | 2024 | https://conductscience.org/library/papers/38343611 | PubMed |
| 38183609 | FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease. | Hepatol Int | 2024 | https://conductscience.org/library/papers/38183609 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PPARGC1A | 10891 | PubTator's text mining | https://conductscience.org/library/genes/10891 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32289481
GET https://conductscience.org/api/papers/v1/32289481/cited_by?page=2